• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多器官人类代谢体外模型中的异速生长比例和细胞比例。

Allometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism.

机构信息

CNR Institute of Clinical Physiology , Pisa , Italy ; Interdepartmental Research Center "E. Piaggio", University of Pisa , Pisa , Italy.

Interdepartmental Research Center "E. Piaggio", University of Pisa , Pisa , Italy.

出版信息

Front Bioeng Biotechnol. 2014 Dec 17;2:74. doi: 10.3389/fbioe.2014.00074. eCollection 2014.

DOI:10.3389/fbioe.2014.00074
PMID:25566537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4269269/
Abstract

Intelligent in vitro models able to recapitulate the physiological interactions between tissues in the body have enormous potential as they enable detailed studies on specific two-way or higher order tissue communication. These models are the first step toward building an integrated picture of systemic metabolism and signaling in physiological or pathological conditions. However, the rational design of in vitro models of cell-cell or cell-tissue interaction is difficult as quite often cell culture experiments are driven by the device used, rather than by design considerations. Indeed, very little research has been carried out on in vitro models of metabolism connecting different cell or tissue types in a physiologically and metabolically relevant manner. Here, we analyze the physiological relationship between cells, cell metabolism, and exchange in the human body using allometric rules, downscaling them to an organ-on-a-plate device. In particular, in order to establish appropriate cell ratios in the system in a rational manner, two different allometric scaling models (cell number scaling model and metabolic and surface scaling model) are proposed and applied to a two compartment model of hepatic-vascular metabolic cross-talk. The theoretical scaling studies illustrate that the design and hence relevance of multi-organ models is principally determined by experimental constraints. Two experimentally feasible model configurations are then implemented in a multi-compartment organ-on-a-plate device. An analysis of the metabolic response of the two configurations demonstrates that their glucose and lipid balance is quite different, with only one of the two models recapitulating physiological-like homeostasis. In conclusion, not only do cross-talk and physical stimuli play an important role in in vitro models, but the numeric relationship between cells is also crucial to recreate in vitro interactions, which can be extrapolated to the in vivo reality.

摘要

能够重现体内组织之间生理相互作用的智能体外模型具有巨大的潜力,因为它们能够对特定的双向或更高阶组织通讯进行详细研究。这些模型是构建生理或病理条件下系统代谢和信号传递综合图的第一步。然而,设计细胞-细胞或细胞-组织相互作用的体外模型具有挑战性,因为细胞培养实验通常是由所用设备驱动的,而不是由设计考虑驱动的。事实上,很少有研究致力于以生理上和代谢上相关的方式连接不同细胞或组织类型的代谢体外模型。在这里,我们使用比例缩放规则分析细胞、细胞代谢和人体中物质交换之间的生理关系,并将其缩小到器官板上的装置。特别是,为了以合理的方式在系统中建立适当的细胞比例,提出并应用了两种不同的比例缩放模型(细胞数量缩放模型和代谢与表面缩放模型)到肝血管代谢串扰的两室模型中。理论比例缩放研究表明,多器官模型的设计和因此的相关性主要取决于实验限制。然后在多腔室器官板装置中实施了两种实验可行的模型配置。对两种配置的代谢响应分析表明,它们的葡萄糖和脂质平衡非常不同,只有两种模型中的一种再现了类似生理的动态平衡。总之,不仅串扰和物理刺激在体外模型中起着重要作用,而且细胞之间的数量关系对于重现体外相互作用也至关重要,这可以外推到体内现实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/cdb334e6dd1e/fbioe-02-00074-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/07d3d2d9fd4b/fbioe-02-00074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/7783a4c73e7a/fbioe-02-00074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/f48f7e5dd876/fbioe-02-00074-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/e7e0b269d356/fbioe-02-00074-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/5ed28c02e03a/fbioe-02-00074-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/cdb334e6dd1e/fbioe-02-00074-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/07d3d2d9fd4b/fbioe-02-00074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/7783a4c73e7a/fbioe-02-00074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/f48f7e5dd876/fbioe-02-00074-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/e7e0b269d356/fbioe-02-00074-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/5ed28c02e03a/fbioe-02-00074-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deeb/4269269/cdb334e6dd1e/fbioe-02-00074-g006.jpg

相似文献

1
Allometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism.多器官人类代谢体外模型中的异速生长比例和细胞比例。
Front Bioeng Biotechnol. 2014 Dec 17;2:74. doi: 10.3389/fbioe.2014.00074. eCollection 2014.
2
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
3
Multi-level regulation and metabolic scaling.多层次调节与代谢比例关系
J Exp Biol. 2005 May;208(Pt 9):1627-34. doi: 10.1242/jeb.01503.
4
On being the right size: scaling effects in designing a human-on-a-chip.大小要合适:在设计人体芯片时的缩放效应。
Integr Biol (Camb). 2013 Sep;5(9):1149-61. doi: 10.1039/c3ib40040a.
5
Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).使用集成微生理系统(MPS)进行转化药代动力学和药效学应用的多功能缩放方法。
Integr Biol (Camb). 2017 Apr 18;9(4):290-302. doi: 10.1039/c6ib00243a.
6
An in vitro model of glucose and lipid metabolism in a multicompartmental bioreactor.多室生物反应器中葡萄糖和脂质代谢的体外模型。
Biotechnol J. 2012 Jan;7(1):117-26. doi: 10.1002/biot.201100177. Epub 2011 Oct 7.
7
Heterogeneity of cells may explain allometric scaling of metabolic rate.细胞的异质性可能解释代谢率的异速生长缩放。
Biosystems. 2015 Apr;130:11-6. doi: 10.1016/j.biosystems.2015.02.003. Epub 2015 Feb 7.
8
Data from necropsy studies and in vitro tissue studies lead to a model for allometric scaling of basal metabolic rate.尸检研究和体外组织研究的数据得出了基础代谢率异速生长缩放的模型。
Theor Biol Med Model. 2005 Sep 27;2:39. doi: 10.1186/1742-4682-2-39.
9
Allometric scaling in-vitro.体内的异速生长比例。
Sci Rep. 2017 Feb 7;7:42113. doi: 10.1038/srep42113.
10
Differentiating causality and correlation in allometric scaling: ant colony size drives metabolic hypometry.区分异速生长比例中的因果关系和相关性:蚁群大小驱动代谢减缓。
Proc Biol Sci. 2017 Feb 22;284(1849). doi: 10.1098/rspb.2016.2582.

引用本文的文献

1
Pillar arrays as tunable interfacial barriers for microphysiological systems.作为微生理系统可调界面屏障的柱状阵列
Res Sq. 2025 Jan 16:rs.3.rs-5776581. doi: 10.21203/rs.3.rs-5776581/v1.
2
Citicoline Eye Drops Protect Trabecular Meshwork Cells from Oxidative Stress Injury in a 3D In Vitro Glaucoma Model.胞磷胆碱滴眼液在体外青光眼模型中保护小梁细胞免受氧化应激损伤。
Int J Mol Sci. 2022 Sep 27;23(19):11375. doi: 10.3390/ijms231911375.
3
gH625-liposomes deliver PACAP through a dynamic model of the blood-brain barrier.gH625脂质体通过血脑屏障的动态模型递送垂体腺苷酸环化酶激活肽。

本文引用的文献

1
On being the right size: scaling effects in designing a human-on-a-chip.大小要合适:在设计人体芯片时的缩放效应。
Integr Biol (Camb). 2013 Sep;5(9):1149-61. doi: 10.1039/c3ib40040a.
2
A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture.一种通过 3D 人肝和皮肤组织共培养得到验证的用于长期培养和物质测试的动态多器官芯片。
Lab Chip. 2013 Sep 21;13(18):3538-47. doi: 10.1039/c3lc50234a.
3
Engineering challenges for instrumenting and controlling integrated organ-on-chip systems.
Front Physiol. 2022 Aug 19;13:932099. doi: 10.3389/fphys.2022.932099. eCollection 2022.
4
Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics.利用多器官芯片研究代谢:用于疾病建模、药代动力学和药效动力学的新工具。
Open Biol. 2022 Mar;12(3):210333. doi: 10.1098/rsob.210333. Epub 2022 Mar 2.
5
Construction of 3D hierarchical tissue platforms for modeling diabetes.用于模拟糖尿病的三维分层组织平台的构建
APL Bioeng. 2021 Oct 20;5(4):041506. doi: 10.1063/5.0055128. eCollection 2021 Dec.
6
Scaling of joint mass and metabolism fluctuations in in silico cell-laden spheroids.细胞微载体球中关节质量和代谢波动的比例缩放。
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38). doi: 10.1073/pnas.2025211118.
7
Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review.肺微生理系统在COVID-19建模和药物发现中的应用:综述
Biodes Manuf. 2021;4(4):757-775. doi: 10.1007/s42242-021-00136-5. Epub 2021 Jun 18.
8
Patient-Specific Organoid and Organ-on-a-Chip: 3D Cell-Culture Meets 3D Printing and Numerical Simulation.患者特异性类器官和器官芯片:3D 细胞培养与 3D 打印和数值模拟的结合。
Adv Biol (Weinh). 2021 Jun;5(6):e2000024. doi: 10.1002/adbi.202000024. Epub 2021 Apr 15.
9
Can Polyphenols in Eye Drops Be Useful for Trabecular Protection from Oxidative Damage?眼药水当中的多酚类物质对小梁网免受氧化损伤是否有作用?
J Clin Med. 2020 Nov 6;9(11):3584. doi: 10.3390/jcm9113584.
10
Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease.利用患者来源的中脑类器官探索帕金森病的分子基础
Front Neurol. 2020 Sep 4;11:1005. doi: 10.3389/fneur.2020.01005. eCollection 2020.
集成式器官芯片系统的仪器和控制工程挑战。
IEEE Trans Biomed Eng. 2013 Mar;60(3):682-90. doi: 10.1109/TBME.2013.2244891. Epub 2013 Feb 1.
4
Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia.在正常血糖和高血糖条件下,用 3 种组织的体外模型研究葡萄糖和脂肪酸代谢。
PLoS One. 2012;7(4):e34704. doi: 10.1371/journal.pone.0034704. Epub 2012 Apr 11.
5
Micro total bioassay system for oral drugs: evaluation of gastrointestinal degradation, intestinal absorption, hepatic metabolism, and bioactivity.口服药物的微型全生物测定系统:胃肠道降解、肠道吸收、肝脏代谢及生物活性评估
Anal Sci. 2012;28(3):197-9. doi: 10.2116/analsci.28.197.
6
Engineering Quasi-Vivo in vitro organ models.工程化类器官体外模型。
Adv Exp Med Biol. 2012;745:138-53. doi: 10.1007/978-1-4614-3055-1_9.
7
An in vitro model of glucose and lipid metabolism in a multicompartmental bioreactor.多室生物反应器中葡萄糖和脂质代谢的体外模型。
Biotechnol J. 2012 Jan;7(1):117-26. doi: 10.1002/biot.201100177. Epub 2011 Oct 7.
8
Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system.在静态和灌注流体系统中,基于细胞的体外分析方法进行非特异性结合和 ADME 过程的动力学建模。
Toxicol Lett. 2011 Sep 10;205(3):310-9. doi: 10.1016/j.toxlet.2011.06.021. Epub 2011 Jun 23.
9
The role of body-on-a-chip devices in drug and toxicity studies.在药物和毒性研究中,芯片上器官设备的作用。
Annu Rev Biomed Eng. 2011 Aug 15;13:55-72. doi: 10.1146/annurev-bioeng-071910-124629.
10
A flexible bioreactor system for constructing in vitro tissue and organ models.一种用于构建体外组织和器官模型的灵活生物反应器系统。
Biotechnol Bioeng. 2011 Sep;108(9):2129-40. doi: 10.1002/bit.23164. Epub 2011 May 31.